Abaloparatide Injection (80 mcg): Clinical Trials

1 trial of Abaloparatide Injection (80 mcg), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Abaloparatide Injection (80 mcg): new trials by email Literature Review of Abaloparatide Injection (80 mcg) trials Research Report on Abaloparatide Injection (80 mcg)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis
Abaloparatide Transdermal (50 mcg), Abaloparatide Transdermal (100 mcg), Abaloparatide Transdermal (150 mcg) - Post Menopausal Osteoporosis
Phase 2CompletedRadius Health, Inc.2502012-09-252020-06-16

Conditions studied

Osteoporosis (1)  ·  Osteoporosis, Postmenopausal (1)

Sponsors

Radius Health, Inc. (1)

Countries

Denmark (1)  ·  Estonia (1)  ·  Poland (1)  ·  United States (1)